Phibro Animal Health (PAHC) Return on Capital Employed (2014 - 2026)
Phibro Animal Health (PAHC) posted quarterly Return on Capital Employed of 15.74% for Q1 2026, up 654.0% year-over-year from 2.09% in Q1 2025, and up 3.77% quarter-over-quarter from 15.17% in Q4 2025.
Phibro Animal Health (PAHC) Return on Capital Employed (2014 - 2026) Analysis & Trends
Phibro Animal Health's Return on Capital Employed history runs 13 years deep, the most recent figure standing at 15.74% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 654.0% year-over-year to 15.74%; the TTM figure through Mar 2026 stood at 15.74% (up 654.0% YoY), while the FY2025 annual figure was 12.58%, up 568.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 15.74%, up from 15.17% in the prior quarter.
- The five-year high for Return on Capital Employed was 15.74% in Q1 2026, with the low at 6.87% in Q2 2024.
- The 5-year median for Return on Capital Employed is 9.14% (2024), against an average of 9.97%.
- The sharpest annual moves came in 2023 and 2026: Return on Capital Employed plunged 295 bps in 2023, then soared 654 bps in 2026.
- Phibro Animal Health's Return on Capital Employed stood at 9.09% in 2022, then dropped by 19 bps to 7.34% in 2023, then grew by 25 bps to 9.14% in 2024, then surged by 66 bps to 15.17% in 2025, then advanced by 4 bps to 15.74% in 2026.
- Business Quant data shows PAHC's Return on Capital Employed at 15.74% in Q1 2026, 15.17% in Q4 2025, and 13.06% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 15.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.74% |
| Dec 31, 2025 | 15.17% |
| Sep 30, 2025 | 13.06% |
| Jun 30, 2025 | 10.56% |
| Mar 31, 2025 | 9.20% |
| Dec 31, 2024 | 9.14% |
| Sep 30, 2024 | 9.00% |
| Jun 30, 2024 | 6.87% |
| Mar 31, 2024 | 7.46% |
| Dec 31, 2023 | 7.34% |
| Sep 30, 2023 | 7.22% |
| Jun 30, 2023 | 9.07% |
| Mar 31, 2023 | 8.89% |
| Dec 31, 2022 | 9.09% |
| Sep 30, 2022 | 10.17% |
| Jun 30, 2022 | 10.77% |
| Mar 31, 2022 | 10.82% |
| Dec 31, 2021 | 11.27% |
| Sep 30, 2021 | 10.76% |
| Jun 30, 2021 | 11.36% |